Figure 9From: The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] Effect of simvastatin allocation on incidence of first cancer by period of follow-up. Symbols and conventions as in Figure 1. Excludes non-melanoma skin cancer.Back to article page